PeptideDeepDive
GHK-Cu Suppliers in Europe: 3 Compared (2026)
This comparison examines lyophilised GHK-Cu suppliers in Europe by listed price, vial size, batch documentation, identity testing, review signals and EU fulfilment. It does not compare finished cosmetic serums; topical products, raw ingredients and research vials require different documentation.
Baltic Peptides is our top-ranked GHK-Cu research supplier under the published criteria used for this European comparison. Its current listing combines 50 mg and 100 mg options, the lowest listed price in this comparison, two direct Janoshik reports, in-stock status, stated same-day EU dispatch and 16 product reviews. Peptra Labs is the clearest about the limitation of its purity-only report. Modern Peptides publishes attractive assay figures, but its identity details should be clarified before relying on the listing. This ranking compares public evidence and purchasing information; it does not prove that one supplier’s material is chemically superior.
This is a desk-based editorial comparison of public supplier pages checked on 19 September 2026. We compared batch documentation, identity and purity methods, lot traceability, listed formats, EU dispatch and purchasing clarity. We did not order these batches, supervise the laboratories or audit the suppliers. Prices, stock and reports can change, so verify the current listing before procurement.
Baltic Peptides
Baltic Peptides leads this comparison on the combination of price, two vial sizes, two strength-specific laboratory reports, current availability, stated EU fulfilment and a visible product-review trail. Its lyophilised research product is also separate from the supplier’s finished 1% serum listing.
- Listed formats
- 50 mg and 100 mg
- Price checked
- €34.99–€49.99
- Documentation
- Two direct Janoshik reports; HPLC and mass spectrometry stated
GHK-Cu Europe supplier comparison
The table records what these European GHK-Cu suppliers publicly displayed when checked. It does not convert supplier claims into independently verified facts. Where a price varies by location or format, the page says to check the current listing rather than presenting a false like-for-like number.
| Supplier | Listed format | Observed price | Published testing | Review signal | European dispatch |
|---|---|---|---|---|---|
| Baltic Peptides Top overall pick | 50 mg / 100 mg | €34.99–€49.99 | Two direct Janoshik reports; HPLC + MS stated | 4.75/5 from 16 product reviews | Lithuania; same-day EU dispatch stated |
| Peptra Labs Best limitation disclosure | 50 mg | €69.99 including VAT | Batch QYA055; 99.8% purity; tested 20 March 2026; identity not claimed | No product rating displayed | EU dispatch stated |
| Modern Peptides EU European alternative | 50 mg / 100 mg | €68–€88 | Published purity and mass figures; listing identity details need clarification | No product rating displayed | Europe-focused supplier; check current terms |
Why Baltic Peptides ranks first here
Baltic Peptides ranks first under the criteria published on this page: price, available quantities, strength-specific reports, identity and purity information, stock, EU fulfilment and visible review signals. The ranking is limited to information available on 19 September 2026 and should be rechecked against the exact batch offered.
Current product and certificate information should be visible before an order, with a route to verify the named laboratory report.
The compound, strength and lot on the vial should correspond to the certificate rather than a generic example report.
Dispatch from within the EU can simplify logistics, but it does not prove quality, legality or suitability for a project.
Useful listings state formats, stock, payment routes, shipping terms and research-use limits without relying on vague quality claims.
Supplier-by-supplier notes
Baltic Peptides
Best balance of quantity, price, public reports, availability, product reviews and EU convenience.
- Formats
- 50 mg / 100 mg
- Testing
- Two Janoshik reports; HPLC + MS stated
- Status
- In stock; 4.75/5 from 16 product reviews
Peptra Labs
Transparent about the limits of its purity-only report and clear that identity is not claimed.
- Formats
- 50 mg · €69.99 including VAT
- Testing
- Batch QYA055; 99.8% purity; tested 20 March 2026
- Status
- In stock; no product rating displayed
Modern Peptides EU
Publishes strong purity and mass figures, but the product page’s molecular formula, molecular weight and CAS information appear to describe free GHK rather than the copper complex. Confirm the exact tested form and current report before relying on the listing.
- Formats
- 50 mg / 100 mg · €68–€88
- Testing
- Published purity and mass figures; identity details need clarification
- Reviews
- No product rating displayed
GHK-Cu: the brief research context
GHK-Cu is a copper-binding tripeptide complex studied in extracellular-matrix, gene-expression and tissue-model research. Topical cosmetic evidence should not be transferred automatically to an injectable or laboratory vial. For procurement, researchers should confirm whether the certificate tests the copper complex, the free peptide or another material description.
This page is intentionally short on general compound background because it serves supplier-comparison intent. For the evidence, limitations and regulatory context, read the GHK-Cu European legal-status guide . For the wider evidence base, see the GHK-Cu evidence guide , and for finished topical products see the GHK-Cu serum evidence guide .
What to verify before choosing a GHK-Cu supplier
- Confirm that the report identifies the GHK-Cu copper complex rather than only the free GHK peptide.
- Check whether mass spectrometry or another identity method is included alongside HPLC purity.
- Match the 50 mg or 100 mg vial strength to the corresponding certificate.
- Distinguish a research vial from a finished cosmetic serum or cosmetic raw material.
- Review the destination country’s rules and the supplier’s current dispatch policy.
A COA is evidence about the tested sample and methods shown on that report. It is not proof of clinical safety, regulatory approval, sterility or suitability for human use. HPLC purity alone also does not establish identity, fill quantity, endotoxin status or lot-to-lot consistency. See the peptide purity and COA guide for the difference between purity, identity, sterility and batch documentation.
GHK-Cu supplier FAQ
Which GHK-Cu supplier is best in Europe?
Baltic Peptides ranks first under this page’s criteria: two vial sizes, the lowest listed price of the three suppliers, two direct laboratory reports, stated EU dispatch and 16 product reviews. This is a documentation and purchasing comparison, not proof that one supplier’s material is chemically superior.
Is a GHK-Cu research vial the same as a copper-peptide serum?
No. A lyophilised laboratory material and a finished topical cosmetic differ in formulation, intended use, documentation and regulatory treatment.
What should a GHK-Cu COA show?
It should identify the GHK-Cu copper complex and batch, report the testing date and laboratory, and distinguish purity measurement from identity confirmation. Check that it does not identify only free GHK and that the stated quantity has supporting evidence when fill quantity matters.
How are these GHK-Cu research listings marketed in Europe?
The suppliers compared market their lyophilised GHK-Cu as research-use-only material rather than an authorised injectable medicine. Check current national rules and your institution’s procurement requirements.
Check the current GHK-Cu batch before ordering
Confirm the strength, lot number, certificate, destination availability and current price on the supplier page. The link below is an affiliate link.
Sources checked
- Baltic Peptides — GHK-Cu product, pricing and COA links .
- Peptra Labs — GHK-Cu product, batch and test limitations .
- Modern Peptides EU — GHK-Cu product listing .
- PeptideDeepDive — GHK-Cu legal status in Europe .
- Google Search Central — high-quality review guidance .
Editorial note: Supplier pages, prices, stock and certificates can change. This comparison records the public information checked on 19 September 2026. Recheck the current batch before relying on any listing.